Companies / CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc.

Nasdaq: CTMXCIK 1501989SOUTH SAN FRANCISCO, CA

Financials · FY2025

Revenue$76.20M
Net income$-17.37M
Total debt$1.57M
Cash$17.22M
Diluted EPS—
Shares outstanding217.9M

Ownership

217.9M shares outstanding · as of Jul 31, 2026
0.87%Insiders
Ownership
Insiders0.87%1,886,076
10%+ / strategic22.45%48,927,072
Institutions56.82%123,817,275
Public float19.86%43,268,861

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
McCarthy Sean A.CEOCEO · Director
0.50%1,078,922
Belvin MarciaSVP, Chief Scientific Officer
0.14%300,760
Ogden ChristopherChief Financial Officer
0.14%296,948
Chu Yu-WayeChief Medical Officer
0.09%189,446
Lester RachaelChief Business Officer
<0.01%20,000
Jones Elaine VDirector
——
Meyers James RDirector
——

Institutional holders 133

View all →
HolderValue% of shares
Fmr LLC$105.17M11.33%
VR Adviser, LLC$66.29M7.14%
BlackRock, Inc.$65.85M8.06%
Perceptive Advisors LLC$47.46M4.63%
State Street Corporation$44.05M5.39%
Kynam Capital Management, LP$38.20M4.11%
Vanguard Group Inc$36.11M3.89%
Commodore Capital LP$32.77M3.53%
Baker Bros. Advisors LP$23.39M2.28%
Point72 Asset Management, L.P.$22.11M2.38%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 17, 2026McCarthy Sean A.
CEO
SellCommon Stock$764.1K-119K
-9.93%
1,078,922
0.50% of shares
medium
Mar 17, 2026Belvin Marcia
Executive
SellCommon Stock$202.3K-31K
-9.48%
300,760
0.14% of shares
medium
Mar 17, 2026Chu Yu-Waye
Executive
SellCommon Stock$136.7K-21K
-10.10%
189,446
0.09% of shares
medium
Mar 17, 2026Ogden Christopher
Executive
SellCommon Stock$124.1K-19K
-6.11%
296,948
0.14% of shares
medium
Feb 2, 2026McCarthy Sean A.
CEO
GrantCommon Stock$0+210K
+21.26%
1,197,891
0.55% of shares
low
Feb 2, 2026Lester Rachael
Executive
GrantCommon Stock$0+20K
20,000
<0.01% of shares
low
Feb 2, 2026Chu Yu-Waye
Executive
GrantCommon Stock$0+75K
+55.26%
210,725
0.10% of shares
low
Feb 2, 2026Belvin Marcia
Executive
GrantCommon Stock$0+60K
+22.04%
332,252
0.15% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
State Street CorporationPassive13G—11,747,236—
Vanguard Group IncPassive13G/A—0—
Orbimed Advisors LLCPassive13G/A—3,525,650—
Tang Capital Management, LLCPassive13G/A—0—
Fmr LLCPassive13G/A—24,688,109—
Kynam Capital Management, LPPassive13G—8,966,077—
Perceptive Advisors LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CTMX——23284F105—